From: A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis
Prediction rule cut-off point* | Sensitivity (%)** | Specificity (%)** | Positive predictive value (%)** | Negative predictive value (%)** | Patients referred for PET (%)*** |
---|---|---|---|---|---|
0 | 100 (77/77) | 0 (0/18) | 81 (77/95) | - | 0 (/95) |
1 | 94.8 (73/77) | 27.8 (5/18) | 84.8 (73/86) | 55.5 (5/9) | 9.5 (9/95) |
2 | 93.5 (72/77) | 33.3 (6/18) | 85.7 (72/84) | 54.5 (6/11) | 11.6 (11/95) |
3 | 90.9 (70/77) | 38.9 (7/18) | 86.4 (70/81) | 50.0 (7/14) | 14.7 (14/95) |
4 | 85.7 (66/77) | 55.6 (10/18) | 89.2 (66/74) | 47.6 (10/21) | 22.1 (21/95) |
5 | 81.8 (63/77) | 55.6 (10/18) | 88.7 (63/71) | 41.7 (10/24) | 25.3 (24/95) |
6 | 79.2 (61/77) | 66.7 (12/18) | 91.0 (61/76) | 42.9 (12/28) | 29.5 (28/95) |
7 | 77.9 (60/77) | 72.2 (13/18) | 92.3 (60/65) | 43.3 (13/30) | 31.6 (30/95) |
8 | 76.6 (59/77) | 72.2 (13/18) | 92.2 (59/64) | 41.9 (13/31) | 32.6 (31/95) |
9 | 72.7 (56/77) | 83.3 (15/18) | 94.9 (56/59) | 41.7 (15/36) | 37.9 (36/95) |
10 | 64.9 (50/77) | 94.4 (17/18) | 98.0 (50/51) | 38.6 (17/44) | 46.3 (44/95) |
11 | 53.2 (41/77) | 94.4 (17/18) | 97.6 (41/42) | 32.0 (17/53) | 55.8 (53/95) |
12 | 48.1 (37/77) | 94.4 (17/18) | 97.4 (37/38) | 29.8 (17/57) | 60.0 (57/95) |
13 | 41.6 (32/77) | 94.4 (17/18) | 97.0 (32/33) | 27.4 (17/62) | 65.3 (62/95) |
14 | 35.1 (27/77) | 94.4 (17/18) | 96.4 (27/28) | 25.4 (17/67) | 70.5 (67/95) |
15 | 27.3 (21/77) | 100 (18/18) | 100 (21/21) | 24.3 (18/74) | 77.9 (74/95) |
16 | 24.6 (19/77) | 100 (18/18) | 100 (19/19) | 23.7 (18/76) | 80.0 (76/95) |
17 | 20.8 (16/77) | 100 (18/18) | 100 (16/16) | 22.8 (18/79) | 83.2 (79/95) |
18 | 13.0 (10/77) | 100 (18/18) | 100 (10/10) | 21.2 (18/85) | 89.5 (85/95) |
19 | 7.8 (6/77) | 100 (18/18) | 100 (6/6) | 20.2 (18/89) | 93.7 (89/95) |
20 | 7.8 (6/77) | 100 (18/18) | 100 (6/6) | 20.2 (18/89) | 93.7 (89/95) |
21 | 3.9 (3/77) | 100 (18/18) | 100 (3/3) | 19.6 (18/92) | 96.8 (92/95) |